In contrast, only 50% of glioma xenograft models showed a phospho-MEK1 overexpression, as compared to the non-tumor brain tissue, and, when overexpressed, phospho-MEK1 expression level did not exceed a 10-fold increase (Fig. 1C). The gene discussed is MAP2K1; the disease is glioma.